Clinical Trial

Colchicine in Atrial Fibrillation to Prevent Stroke

Study Description

Colchicine in Atrial Fibrillation to Prevent Stroke

The purpose of this study is to determine the feasibility of performing a randomized controlled trial to investigate the efficacy of an anti-inflammatory drug, colchicine, at reducing well validated markers of thrombosis (D-dimer) and inflammation (hs-CRP).

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Recruiting patients only Recruiting patients only

Drug - Colchicine

Colchicine 0.6mg twice daily

Drug - Placebo

Placebo Colchicine

Additional Information

Official Study Title

Targeting Inflammation in Atrial Fibrillation to Prevent Ischemic Stroke: A Feasibility Study Evaluating the Effect of Colchicine on D-dimer and Hs-CRP in Anticoagulated Patients With Atrial Fibrillation

Clinical Trial ID

NCT02282098

ParticipAid ID

xboONb